These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2372230)

  • 1. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung.
    Suzuki Y; Fukuda K
    Arch Toxicol; 1990; 64(3):169-76. PubMed ID: 2372230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism of ascorbic acid and glutathione in the reduction of hexavalent chromium in vitro.
    Suzuki Y
    Ind Health; 1990; 28(1):9-19. PubMed ID: 2323964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid.
    Suzuki Y
    Arch Toxicol; 1988; 62(2-3):116-22. PubMed ID: 3196146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anion-exchange high-performance liquid chromatographic determination of ascorbic acid and hexavalent chromium in rat lung preparations after treatment with sodium chromate in vitro and in vivo.
    Suzuki Y; Fukuda K
    J Chromatogr; 1989 Apr; 489(2):283-90. PubMed ID: 2753952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of chromium by rat liver mitochondria.
    Alexander J; Aaseth J; Norseth T
    Toxicology; 1982; 24(2):115-22. PubMed ID: 7135409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromium (VI) reducing capacity of ascorbic acid and of human plasma in vitro.
    Capellmann M; Bolt HM
    Arch Toxicol; 1992; 66(1):45-50. PubMed ID: 1580793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of Cr(VI) by ascorbate but not glutathione is a low oxidant-generating process.
    Wong V; Armknecht S; Zhitkovich A
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):192-6. PubMed ID: 22572042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione.
    Kortenkamp A; Casadevall M; Faux SP; Jenner A; Shayer RO; Woodbridge N; O'Brien P
    Arch Biochem Biophys; 1996 May; 329(2):199-207. PubMed ID: 8638952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
    De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
    Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of PM2 DNA breaks in the course of reduction of chromium(VI) by glutathione.
    Kortenkamp A; Ozolins Z; Beyersmann D; O'Brien P
    Mutat Res; 1989 Feb; 216(1):19-26. PubMed ID: 2918862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of chromium compounds on the respiratory system. 2. Difference between water-soluble hexavalent and trivalent compounds].
    Adachi S; Yoshimura H; Miyayama R; Katayama H; Takemoto K; Kawai H
    Sangyo Igaku; 1983 May; 25(3):149-54. PubMed ID: 6655982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of reducing compounds on the formation of DNA-protein cross-links in HL-60 cells induced by hexavalent chromium.
    Capellmann M; Mikalsen A; Hindrum M; Alexander J
    Carcinogenesis; 1995 May; 16(5):1135-9. PubMed ID: 7767976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney.
    Scibior A; Zaporowska H
    J Toxicol Environ Health A; 2007 Apr; 70(8):696-704. PubMed ID: 17365624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.
    Standeven AM; Wetterhahn KE
    Carcinogenesis; 1992 Aug; 13(8):1319-24. PubMed ID: 1499083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual oil fly ash inhalation in guinea pigs: influence of absorbate and glutathione depletion.
    Norwood J; Ledbetter AD; Doerfler DL; Hatch GE
    Toxicol Sci; 2001 May; 61(1):144-53. PubMed ID: 11294985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic review: is ascorbic acid of value in chromium poisoning and chromium dermatitis?
    Bradberry SM; Vale JA
    J Toxicol Clin Toxicol; 1999; 37(2):195-200. PubMed ID: 10382555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
    Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
    Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates.
    Standeven AM; Wetterhahn KE
    Carcinogenesis; 1991 Sep; 12(9):1733-7. PubMed ID: 1893533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites.
    Casadevall M; da Cruz Fresco P; Kortenkamp A
    Chem Biol Interact; 1999 Nov; 123(2):117-32. PubMed ID: 10597905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Extracellular Detoxification Is a Link to Different Carcinogenicity among Chromates in Rodent and Human Lungs.
    Krawic C; Luczak MW; Zhitkovich A
    Chem Res Toxicol; 2017 Sep; 30(9):1720-1729. PubMed ID: 28759204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.